INFLECTRA

This brand name is authorized in Albania, Austria, Australia, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, United Kingdom, United States

Active ingredients

The drug INFLECTRA contains one active pharmaceutical ingredient (API):

1 Infliximab UNII B72HH48FLU - INFLIXIMAB

Infliximab is a chimeric human-murine monoclonal antibody that binds with high affinity to both soluble and transmembrane forms of TNFα but not to lymphotoxin α (TNFβ). Read about Infliximab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INFLECTRA Powder for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AB02	Infliximab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 631/96
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10057H, 10067W, 10184B, 10196P, 11389K, 11396T, 11399Y, 11400B, 11412P, 11423F, 11424G, 11432Q, 11445J, 11448M, 11449N, 11450P, 11459D, 11461F, 11481G, 11482H, 11483J, 11486M, 11487N, 11488P, 11489Q, 11490R, 11497D, 11498E, 11514B, 11515C, 11590B, 11595G, 11605T, 11606W, 11796W, 11797X, 5753T, 5754W, 5755X, 5756Y, 5757B, 5758C, 6397Q, 6448J, 6496X, 9612X, 9613Y, 9617E, 9654D, 9674E
Country: CA	Health Products and Food Branch	Identifier(s): 02419475
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 05702617, 06575061, 08798546, 10315704, 10315710, 10315727, 10315733, 10315756, 11144179, 11144191, 11144222, 11144245, 11155869, 11155875, 11155906, 11155912, 11155929, 11174128, 11174140, 11174157, 11174163, 11217300, 11217317, 11217323, 11217346, 11217352, 11344961, 11532243, 11532266, 11532272, 11649169, 11649181, 11649198, 11649206, 11668020, 12389084, 12531932, 12727931, 12728221, 12774132, 13333625, 13704091, 13753333, 13753356, 13753362, 13753379, 13753385, 13837544, 13892477, 13892566, 14277716, 14277722, 14341360, 14341408, 15267418, 15267424, 15267430, 15267447, 15389972, 15389989, 15389995, 15390001, 15390018, 15434017, 15434023, 15434046, 15434052, 15434069, 16209914, 16370058, 16370064, 16370070, 16370087, 16370093, 16585818, 16743803, 16743826, 16743832, 17180437, 17180466, 17312583
Country: EE	Ravimiamet	Identifier(s): 1624878, 1624889, 1624890, 1624902, 1665907
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 113854001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 456703
Country: FR	Base de données publique des médicaments	Identifier(s): 61467125
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 289433
Country: IT	Agenzia del Farmaco	Identifier(s): 043010014, 043010026, 043010038, 043010040, 043010053
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1071198, 1071199, 1071200, 1071201, 1071202
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 54542
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 16219
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100270720
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64826001, W64826002, W64826003, W64826004, W64826005
Country: US	FDA, National Drug Code	Identifier(s): 0069-0809